Detalles de la búsqueda
1.
Choosing and using non-steroidal anti-inflammatory drugs in haemophilia.
Haemophilia
; 22(2): 179-187, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26538453
2.
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.
Thromb Res
; 170: 60-68, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30121005
3.
Should we abandon the APTT for monitoring unfractionated heparin?
Thromb Res
; 157: 157-161, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28759760
4.
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
J Thromb Haemost
; 14(11): 2177-2186, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27541499
5.
Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
J Thromb Haemost
; 13(7): 1264-73, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25850997
6.
Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.
Thromb Res
; 135(2): 388-93, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25555316
7.
Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.
J Thromb Haemost
; 12(11): 1801-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25196808
8.
Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease.
Int J Lab Hematol
; 37(4): e75-7, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25428553
9.
Comparative sensitivity of commonly used thromboplastins to ex vivo therapeutic rivaroxaban levels.
Thromb Haemost
; 112(2): 421-3, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24671135
Resultados
1 -
9
de 9
1
Próxima >
>>